EODData

FRA, 6VX: HEALIOS K.K.

04 Nov 2026
LAST:

1.310

CHANGE:
 0.07
OPEN:
1.310
HIGH:
1.310
ASK:
0.000
VOLUME:
0
CHG(%):
5.07
PREV:
1.380
LOW:
1.310
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 261.3101.3101.3101.3100
03 Nov 261.3801.3801.3801.3800
02 Nov 261.3901.3901.3901.3900
30 Oct 261.4501.4501.4501.4500
29 Oct 261.4901.4901.4901.4900
28 Oct 261.5201.5201.5201.5200
27 Oct 261.4901.4901.4901.4900
23 Oct 261.3901.3901.3901.3900
22 Oct 261.4201.4201.4201.4200
21 Oct 261.4701.4701.4701.4700

PROFILE

Name:HEALIOS K.K.
About:Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company develops HLCM051, which is preparing for phase 3 clinical trial, as well as preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is in phase 2/3 and phase 3 clinical trial to treat ischemic stroke; and HLCM051, which is in phase 2 clinical trial to treat trauma. It also develops HLCR011, which is in phase 1/2 clinical trial for the treatment of retinal pigmen epithelium and age-related macular degeneration; and HLCN061, which is in discovery and preclinical trial for treating solid tumors. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.
Sector:Healthcare
Industry:Biotechnology
Address:Hibiya Mitsui Tower, WORK STYLING, Tokyo, Japan, 100-0006
Website:https://www.healios.co.jp
ISIN:JP3835100003
LEI:3538005FFIDTDLUZOE53

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:145.00 
PEG Ratio:0.00 
Price to Sales:3.47 
Price to Book:3.96 
Profit Margin:3.51 
Operating Margin:-181.86 
Return on Assets:-0.13 
Return on Equity:0.04 
Revenue:334.9K 
Shares:115.42M 
Market Cap:151.2M 

TECHNICAL INDICATORS

MA5:1.407.2%
MA10:1.439.2%
MA20:1.4913.4%
MA50:1.4914.1%
MA100:1.396.1%
MA200:1.6324.7%
RSI14:33.77 
WPR14:-100.00 
MTM14:-0.16
ROC14:-0.11 
ATR:0.06 
Week High:1.5216.0%
Week Low:1.310.0%
Month High:1.6929.0%
Month Low:1.3124.7%
Year High:2.68104.6%
Year Low:1.0524.8%